Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
Crossref DOI link: https://doi.org/10.1186/s13058-015-0524-0
Published Online: 2015-02-11
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kren, Betsy T
Unger, Gretchen M
Abedin, Md J
Vogel, Rachel I
Henzler, Christine M
Ahmed, Khalil
Trembley, Janeen H
License valid from 2015-02-11